Bank of New York Mellon’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.1K | Sell |
17,795
-320,032
| -95% | -$290K | ﹤0.01% | 4099 |
|
|
2025
Q1 | $153K | Hold |
337,827
| – | – | ﹤0.01% | 3926 |
|
|
2024
Q4 | $170K | Buy |
337,827
+110
| +0% | +$55 | ﹤0.01% | 3960 |
|
|
2024
Q3 | $306K | Sell |
337,717
-98,241
| -23% | -$88.9K | ﹤0.01% | 3746 |
|
|
2024
Q2 | $435K | Buy |
435,958
+114,762
| +36% | +$114K | ﹤0.01% | 3647 |
|
|
2024
Q1 | $475K | Sell |
321,196
-36,940
| -10% | -$54.7K | ﹤0.01% | 3550 |
|
|
2023
Q4 | $390K | Buy |
358,136
+1,275
| +0.4% | +$1.39K | ﹤0.01% | 3687 |
|
|
2023
Q3 | $421K | Hold |
356,861
| – | – | ﹤0.01% | 3640 |
|
|
2023
Q2 | $503K | Buy |
356,861
+286,033
| +404% | +$403K | ﹤0.01% | 3585 |
|
|
2023
Q1 | $106K | Hold |
70,828
| – | – | ﹤0.01% | 4064 |
|
|
2022
Q4 | $82.9K | Buy |
70,828
+1
| +0% | +$1 | ﹤0.01% | 4151 |
|
|
2022
Q3 | $80K | Hold |
70,827
| – | – | ﹤0.01% | 4238 |
|
|
2022
Q2 | $112K | Sell |
70,827
-340,068
| -83% | -$538K | ﹤0.01% | 4201 |
|
|
2022
Q1 | $633K | Sell |
410,895
-10,349
| -2% | -$15.9K | ﹤0.01% | 3574 |
|
|
2021
Q4 | $1.03M | Sell |
421,244
-3,765
| -0.9% | -$9.22K | ﹤0.01% | 3370 |
|
|
2021
Q3 | $1.07M | Buy |
425,009
+43,794
| +11% | +$110K | ﹤0.01% | 3351 |
|
|
2021
Q2 | $1.09M | Buy |
381,215
+308,316
| +423% | +$879K | ﹤0.01% | 3355 |
|
|
2021
Q1 | $171K | Sell |
72,899
-8,926
| -11% | -$20.9K | ﹤0.01% | 4092 |
|
|
2020
Q4 | $144K | Buy |
81,825
+2,940
| +4% | +$5.17K | ﹤0.01% | 4032 |
|
|
2020
Q3 | $74K | Hold |
78,885
| – | – | ﹤0.01% | 3981 |
|
|
2020
Q2 | $69K | Sell |
78,885
-331,600
| -81% | -$290K | ﹤0.01% | 3936 |
|
|
2020
Q1 | $340K | Sell |
410,485
-85,292
| -17% | -$70.6K | ﹤0.01% | 3545 |
|
|
2019
Q4 | $441K | Buy |
495,777
+40,054
| +9% | +$35.6K | ﹤0.01% | 3646 |
|
|
2019
Q3 | $447K | Buy |
455,723
+46,819
| +11% | +$45.9K | ﹤0.01% | 3589 |
|
|
2019
Q2 | $449K | Sell |
408,904
-61,374
| -13% | -$67.4K | ﹤0.01% | 3649 |
|
|
2019
Q1 | $616K | Buy |
470,278
+61,397
| +15% | +$80.4K | ﹤0.01% | 3445 |
|
|
2018
Q4 | $373K | Sell |
408,881
-465,232
| -53% | -$424K | ﹤0.01% | 3618 |
|
|
2018
Q3 | $1.8M | Buy |
874,113
+23,088
| +3% | +$47.5K | ﹤0.01% | 2898 |
|
|
2018
Q2 | $1.53M | Buy |
851,025
+38,119
| +5% | +$68.7K | ﹤0.01% | 3002 |
|
|
2018
Q1 | $1.91M | Buy |
812,906
+60,386
| +8% | +$142K | ﹤0.01% | 2827 |
|
|
2017
Q4 | $1.42M | Buy |
752,520
+225,597
| +43% | +$425K | ﹤0.01% | 3033 |
|
|
2017
Q3 | $1.31M | Sell |
526,923
-15,840
| -3% | -$39.4K | ﹤0.01% | 3078 |
|
|
2017
Q2 | $1.5M | Buy |
542,763
+34,093
| +7% | +$94K | ﹤0.01% | 3013 |
|
|
2017
Q1 | $1.54M | Buy |
508,670
+75,660
| +17% | +$228K | ﹤0.01% | 3011 |
|
|
2016
Q4 | $1.37M | Buy |
433,010
+139,987
| +48% | +$442K | ﹤0.01% | 3087 |
|
|
2016
Q3 | $999K | Buy |
293,023
+17,906
| +7% | +$61K | ﹤0.01% | 3177 |
|
|
2016
Q2 | $628K | Buy |
275,117
+35,637
| +15% | +$81.3K | ﹤0.01% | 3417 |
|
|
2016
Q1 | $601K | Sell |
239,480
-28,465
| -11% | -$71.4K | ﹤0.01% | 3347 |
|
|
2015
Q4 | $887K | Buy |
267,945
+19,040
| +8% | +$63K | ﹤0.01% | 3236 |
|
|
2015
Q3 | $603K | Sell |
248,905
-48,220
| -16% | -$117K | ﹤0.01% | 3459 |
|
|
2015
Q2 | $871K | Buy |
297,125
+45,396
| +18% | +$133K | ﹤0.01% | 3417 |
|
|
2015
Q1 | $1.01M | Sell |
251,729
-14,042
| -5% | -$56.3K | ﹤0.01% | 3302 |
|
|
2014
Q4 | $800K | Buy |
265,771
+37,452
| +16% | +$113K | ﹤0.01% | 3424 |
|
|
2014
Q3 | $579K | Buy |
228,319
+2,018
| +0.9% | +$5.12K | ﹤0.01% | 3567 |
|
|
2014
Q2 | $557K | Buy |
226,301
+21,693
| +11% | +$53.4K | ﹤0.01% | 3576 |
|
|
2014
Q1 | $543K | Sell |
204,608
-1,982
| -1% | -$5.26K | ﹤0.01% | 3556 |
|
|
2013
Q4 | $600K | Buy |
206,590
+7,711
| +4% | +$22.4K | ﹤0.01% | 3499 |
|
|
2013
Q3 | $610K | Sell |
198,879
-800
| -0.4% | -$2.45K | ﹤0.01% | 3440 |
|
|
2013
Q2 | $638K | Buy |
+199,679
| New | +$638K | ﹤0.01% | 3399 |
|